Parkin transcript variants in rat and human brain

Neurochemical Research

Volumn 29, Issue 9, 2004, Pages 1715-1724

  D'agata, Velia ^a   Cavallaro, Sebastiano ^a  

^a INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

Author keywords

Alternative splicing; autosomal recessive juvenile parkinsonism; parkin; parkin transcript variants; Parkinson's disease

Indexed keywords

NUCLEOTIDE DERIVATIVE; PARKIN; UBIQUITIN;

AMINO ACID COMPOSITION; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; EXON; GENETIC CODE; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GLIA CELL; HUMAN; HUMAN TISSUE; MOLECULAR MECHANICS; NERVE CELL; NEUROCHEMISTRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; RAT; RING OPENING; RNA SPLICING; STRUCTURE ANALYSIS; TRANSLATION INITIATION;

ALTERNATIVE SPLICING; ANIMALS; BRAIN; HUMANS; PARKINSON DISEASE; RATS; TRANSCRIPTION, GENETIC; UBIQUITIN-PROTEIN LIGASES; VARIATION (GENETICS);

ANIMALIA;

EID: 4043095545     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000035807.25370.5e     Document Type: Article

References (37)

1. Skipper, L. and Farrer, M. 2002. Parkinson's genetics: molecular insights for the new millennium. Neuro Toxicology 23:503-514.
2. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., and Shimizu, N. 1998. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605-608.
3. Abbas, N., Lucking, C. B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J. R., Gasser, T., Marconi, R., Broussolle, E., Brefel-Courbon, C., Harhangi, B. S., Oostra, B. A., Fabrizio, E., Bohme, G. A., Pradier, L., Wood, N. W., Filla, A., Meco, G., Denefle, P., Agid, Y., and Brice, A. 1999. A wide variety of mutations in the parkin gene are responsible for autosomal recessive parkinsonism in Europe. French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Hum. Mol. Genet. 8:567-574.
4. Bonifati, V., Lucking, C. B., Fabrizio, E., Periquet, M., Meco, G., and Brice, A. 2001. Three parkin gene mutations in a sibship with autosomal recessive early onset parkinsonism. J. Neurol. Neurosurg. Psychiatry 71:531-534.
5. Bonifati, V., De Michele, G., Lucking, C. B., Durr, A., Fabrizio, E., Ambrosio, G., Vanacore, N., De Mari, M., Marconi, R., Capus, L., Breteler, M. M., Gasser, T., Oostra, B., Wood, N., Agid, Y., Filla, A., Meco, G., and Brice, A. 2001. The parkin gene and its phenotype. Italian PD Genetics Study Group, French PD Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. Neurol. Sci. 22:51-52.
6. Hattori, N., Kitada, T., Matsumine, H., Asakawa, S., Yamamura, Y., Yoshino, H., Kobayashi, T., Yokochi, M., Wang, M., Yoritaka, A., Kondo, T., Kuzuhara, S., Nakamura, S., Shimizu, N., and Mizuno, Y. 1998. Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. Ann. Neurol. 44:935-941.
7. Hattori, N., Matsumine, H., Asakawa, S., Kitada, T., Yoshino, H., Elibol, B., Brooke, A. J., Yamamura, Y., Kobayashi, T., Wang, M., Yoritaka, A., Minoshima, S., Shimizu, N., and Mizuno, Y. 1998. Point mutations (Thr240Arg and Ala311Stop) in the Parkin gene. Biochem. Biophys. Res. Commun. 249:754-758.
8. Hedrich, K., Marder, K., Harris, J., Kann, M., Lynch, T., Meija-Santana, H., Pramstaller, P. P., Schwinger, E., Bressman, S. B., Fahn, S., and Klein, C. 2002. Evaluation of 50 probands with early-onset Parkinson's disease for Parkin mutations. Neurology 58:1239-1246.
9. Kann, M., Jacobs, H., Mohrmann, K., Schumacher, K., Hedrich, K., Garrels, J., Wiegers, K., Schwinger, E., Pramstaller, P. P., Breakefield, X. O., Ozelius, L. J., Vieregge, P., and Klein, C. 2002. Role of parkin mutations in 111 community-based patients with early-onset parkinsonism. Ann. Neurol. 51:621-625.
10. Klein, C., Pramstaller, P. P., Kis, B., Page, C. C., Kann, M., Leung, J., Woodward, H., Castellan, C. C., Scherer, M., Vieregge, P., Breakefield, X. O., Kramer, P. L., and Ozelius, L. J. 2000. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann. Neurol. 48:65-71.
11. Lucking, C. B., Abbas, N., Durr, A., Bonifati, V., Bonnet, A. M., de Broucker, T., De Michele, G., Wood, N. W., Agid, Y., and Brice, A. 1998. Homozygous deletions in parkin gene in European and North African families with autosomal recessive juvenile parkinsonism. The European Consortium on Genetic Susceptibility in Parkinson's Disease and the French Parkinson's Disease Genetics Study Group. Lancet 352:1355-1356.
12. Lucking, C. B., Durr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denefle, P., Wood, N. W., Agid, Y., and Brice, A. 2000. Association between early-onset Parkinson's disease and mutations in the parkin gene. French Parkinson's Disease Genetics Study Group. N. Engl. J. Med. 342:1560-1567.
13. Periquet, M., Lucking, C., Vaughan, J., Bonifati, V., Durr, A., De Michele, G., Horstink, M., Farrer, M., Illarioshkin, S. N., Pollak, P., Borg, M., Brefel-Courbon, C., Denefle, P., Meco, G., Gasser, T., Breteler, M. M., Wood, N., Agid, Y., and Brice, A. the French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's Disease. 2001. Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. Am. J. Hum. Genet. 68:617-626.
14. West, A., Periquet, M., Lincoln, S., Lucking, C. B., Nicholl, D., Bonifati, V., Rawal, N., Gasser, T., Lohmann, E., Deleuze, J. F., Maraganore, D., Levey, A., Wood, N., Durr, A., Hardy, J., Brice, A., and Farrer, M., French Parkinson's Disease Genetics Study Group and the European Consortium on Genetic Susceptibility on Parkinson's Disease. 2002. Complex relationship between Parkin mutations and Parkinson disease. Am. J. Med. Genet. 114:584-591.
15. Takahashi, H., Ohama, E., Suzuki, S., Horikawa, Y., Ishikawa, A., Morita, T., Tsuji, S., and Ikuta, F. 1994. Familial juvenile parkinsonism: clinical and pathologic study in a family. Neurology 44:437-441.
16. Ishikawa, A. and Tsuji, S. 1996. Clinical analysis of 17 patients in 12 Japanese families with autosomal-recessive type juvenile parkinsonism. Neurology 47:160-166.
17. Yamamura, Y., Sobue, I., Ando, K., Iida, M., and Yanagi, T. 1973. Paralysis agitans of early onset with marked diurnal fluctuation of symptoms. Neurology 23:239-244.
18. Morett, E. and Bork, P. 1999. A novel transactivation domain in parkin. Trends Biol. Sci. 24:229-231.
19. van der Reijden, B. A., Erpelinck-Verschueren, C. A., Lowenberg, B., and Jansen, J. H. 1999. TRIADs: a new class of proteins with a novel cysteine-rich signature. Protein Sci. 8:1557-1561.
20. Cookson, M. R. 2003. Parkin's substrates and the pathways leading to neuronal damage. Neuromolecular. Med. 3:1-14.
21. Imai, Y., Soda, M., and Takahashi, R. 2000. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity. J. Biol. Chem. 275:35661-35664.
22. Shimura, H., Hattori, N., Kubo, S. I., Mizuno, Y., Asakawa, S., Minoshima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K, and Suzuki, T. 2000. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25:302-305.
23. Zhang, Y., Gao, J., Chung, K. K., Huang, H., Dawson, V. L., and Dawson, T. M. 2000. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl. Acad. Sci. USA. 97:13354-13359.
24. D'Agata, V., Zhao, W., and Cavallaro, S. 2000. Cloning and distribution of the rat parkin mRNA. Mol. Brain. Res. 75:345-349.
25. D'Agata, V., Grimaldi, M., Pascale, A., and Cavallaro, S. 2000. Regional and cellular expression of parkin in the rat cerebral cortex. Eur. J. Neurosci. 12:3583-3588.
26. D'Agata, V., Zhao, W., Pascale, A., Zohar, O., Scapagnini, G., and Cavallaro, S. 2002. Distribution of parkin in the adult rat brain. Prog. Neuro-Psychoph. 26:519-527.
27. Gu, W. J., Abbas, N., Lagunes, M. Z., Parent, A., Pradier, L., Bohme, G. A., Agid, Y., Hirsch, E. C., Raisman-Vozari, R., and Brice, A. 2000. Cloning of rat parkin cDNA and distribution of parkin in rat brain. J. Neurochem. 74:1773-1776.
28. Stichel, C. C., Augustin, M., Kuhn, K., Zhu, X. R., Engels, P., Ullmer, C., and Lubbert, H. 2000. Parkin expression in the adult mouse brain. Eur. J. Neurosci. 12:4181-4194.
29. Huynh, D. P., Dy, M., Nguyen, D., Kiehl, T. R., and Pulst, S. M. 2001. Differential expression and tissue distribution of parkin isoforms during mouse development. Brain Res. Dev. Brain Res. 130: 173-181.
30. Solano, S. M., Miller, D. W., Augood, S. J., Young, A. B., and Penney, J. B., Jr. 2000. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease. Ann. Neurol. 47:201-210.
31. Horowitz, J. M., Vernace, V. A., Myers, J., Stachowiak, M. K., Hanlon, D. W., Fraley, G. S., and Torres, G. 2001. Immunodetection of Parkin protein in vertebrate and invertebrate brains: a comparative study using specific antibodies. J. Chem. Neuroanat. 21:75-93.
32. Kitada, T., Asakawa, S., Minoshima, S., Mizuno, Y., and Shimizu, N. 2000. Molecular cloning, gene expression, and identification of a splicing valiant of the mouse parkin gene. Mamm. Genome 11:417-421.
33. Sunada, Y., Saito, F., Matsumura, K., and Shimizu, T. 1998. Differential expression of the parkin gene in the human brain and peripheral leukocytes. Neurosci. Lett. 254:180-182.
34. Cavallaro, S., Copani, A., D'Agata, V., Musco, S., Petralia, S., Ventra, C., Stivala, F., Travali, S., and Canonico, P. L. 1996. Pituitary adenylate cyclase activating polypeptide prevents apoptosis in cultured cerebellar granule neurons. Mol. Pharmacol. 50:60-66.
35. Kozak, M. 2001. Constrains on reinitiation of traslation in mammals. Nucleic Acids Res. 29:5226-5232.
36. Dufour, E. 1988. Sequence homologies, hydrophobic profiles and secondary structures of cathepsins B, H and L: comparison with papain and actinidin. Biochimie 70:1335-1342.
37. Asakawa, S., Tsunematsu, K., Takayanagi, A., Sasaki, T., Shimizu, A., Shintani, A., Kawasaki, K., Mungall, A. J., Beck, S., Minoshima, S., and Shimizu, N. 2001. The genomic structure and promoter region of the human parkin gene. Biochem. Biophys. Res. Commun. 286: 863-868.